Feb 25, 2026 by Jeremy BowmanCava's Yearly Revenue Just Topped $1 Billion for the First Time and Its Stock Is Up 20%. Is the Restaurant Stock a Buy?Is the stock ready for another breakout?
Feb 25, 2026 by Bram BerkowitzBillionaire David Tepper Is Calling For Massive Changes at Whirlpool. Here's What Investors Need to Know.Tepper is a legendary investor who runs the fund, Appaloosa Management.
Feb 25, 2026 by Bram BerkowitzParamount Skydance Just Raised its Bid for Warner Bros. -- Is the Netflix Deal Dead?The drama over who will acquire parts of or the entire Warner Bros. company ramped up, with Paramount Skydance increasing its offer.
Feb 25, 2026 by John BallardBlueStem Buys $10 Million of VictoryShares Short-Term Bond ETFThis fixed income ETF targets short-term bonds, balancing yield and liquidity for investors seeking core portfolio stability.
Feb 25, 2026 by Chris MacDonaldHere's Why Dogecoin Barked 13% Higher TodayIt's been quite the day for risk assets, and the world's largest meme coin is clearly feeling it.
Feb 25, 2026 by Dave KovaleskiIs It Too Late to Buy Signet Jewelers Stock?Signet Jewelers has seen its stock jump in value nearly 92% over the past 12 months.
Feb 25, 2026 by Keith NoonanWhy Oddity Tech Stock Is Plummeting TodayOddity's valuation is getting crushed following the company's latest earnings report.
Feb 25, 2026 by Jeremy BowmanCava's Yearly Revenue Just Topped $1 Billion for the First Time and Its Stock Is Up 20%. Is the Restaurant Stock a Buy?Is the stock ready for another breakout?
Feb 25, 2026 by Jonathan PoncianoStructure Therapeutics Stock Soars Over 200% as One Fund Adds to a $242 Million PositionStructure Therapeutics develops oral drugs for chronic diseases, with lead assets targeting diabetes, obesity, and cardiovascular care.
Feb 25, 2026 by Leo Sun4 Things Retail Investors Need to Know About President Trump's Latest Tariff MovesThe new 15% "global" tariff replaces the discontinued "Liberation Day" tariffs.
Feb 25, 2026 by James BrumleyWhat Is One of the Best Tech Stocks to Hold for the Next Decade?The advent of artificial intelligence is about to be bottlenecked in a big way most investors have yet to notice.
Feb 25, 2026 by Jonathan PoncianoProtagonist Stock Up 120%, but One Fund Just Revealed a $170 Million ExitThis biotech innovator develops peptide-based therapies for blood and immune disorders, advancing a pipeline of clinical-stage candidates.
Feb 25, 2026 by Adam SpataccoPalantir Billionaire Peter Thiel Dumped Nvidia, Tesla, Microsoft, and Apple. What Stocks Does He Own for 2026?His latest SEC filing reveals that the venture capitalist's hedge fund sold its entire stock portfolio last quarter.
Feb 25, 2026 by Eric TrieVail Resorts Heads Into Ski Season Backed by Strong Epic Pass SalesBAMCO trimmed its position in Vail Resorts as Epic Pass sales set up the winter season. Vail runs a large portfolio of destination resorts, and investors will be watching whether traffic and guest spending will support the company's earnings outlook.
Feb 25, 2026 by Robert IzquierdoIs Lumen Technologies Stock a Buy or Sell After a Director Dumped 45,000 Shares?This U.S. telecom and technology provider reported a notable insider sale amid a year of significant share price movement.
Feb 25, 2026 by Jonathan PoncianoDisc Medicine Stock Is Swinging, but This Fund's New $52 Million Bet Shows ConvictionDisc Medicine develops therapies for rare blood disorders, leveraging clinical-stage biotech expertise in red blood cell biology.
Feb 25, 2026 by Justin PopePrediction: The Quantum Computing Hype Could Cool Off in 2026 -- Here's WhyDon't rush to buy the dip on these popular quantum computing stocks.
Feb 25, 2026 by Jonathan PoncianoApogee Therapeutics Stock Up 100% as Fund Lifts Stake to $28 MillionThis biotech specializes in monoclonal antibody therapies for inflammatory and immunological diseases with significant unmet needs.
Feb 25, 2026 by Daniel MillerThe Dirty Little Secrets That Sank Ford's Q4There were a couple of unusual factors weighing on Ford's fourth-quarter results. Here's what investors need to know.
Feb 25, 2026 by Daniel FoelberHere's Why Broadcom Stock Is a Buy Before March 4Broadcom is one of the most balanced AI stocks to buy in 2026.
Feb 25, 2026 by Jonathan PoncianoThis Fund Bet $20 Million on RAPT Therapeutics as Stock Surges 500% This Past Year and Buyout Offer EmergesRAPT Therapeutics develops oral therapies for oncology and inflammatory diseases, with lead candidates progressing in clinical trials.
Feb 25, 2026 by Jonathan PoncianoDisc Medicine Lands New $20 Million Investment as FDA Sets Up Potential Q4 CatalystThis clinical-stage biotech develops therapies targeting hematologic disorders, with a pipeline centered on red blood cell biology.
Feb 25, 2026 by Robert IzquierdoDME Capital Scooped Up Over 2 Million Capri Holdings Shares. Is the Stock a Buy?Capri Holdings is a global luxury group behind Versace, Jimmy Choo, and Michael Kors, serving premium markets across multiple continents.
